|
|
|
|
| LEADER |
00000cam a2200000 4500 |
| 001 |
ocn694342017 |
| 003 |
OCoLC |
| 005 |
20240623213015.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
101227s2009 sz o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d S4S
|d OCLCQ
|d MERUC
|d YDXCP
|d DKDLA
|d OCLCQ
|d ZCU
|d ICG
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d DKC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|d OCLCQ
|
| 019 |
|
|
|a 781625393
|
| 020 |
|
|
|a 9789290217145
|
| 020 |
|
|
|a 9290217146
|
| 020 |
|
|
|a 9789290216827
|
| 020 |
|
|
|a 9290216824
|
| 035 |
|
|
|a (OCoLC)694342017
|z (OCoLC)781625393
|
| 043 |
|
|
|a a-jo---
|
| 050 |
|
4 |
|a HD9672 .L42 M43 2009
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a WHO.
|
| 245 |
1 |
0 |
|a Measuring Transparency to Improve Good Governance in the Public Pharmaceutical Sector.
|
| 260 |
|
|
|a Geneva :
|b World Health Organization,
|c 2009.
|
| 300 |
|
|
|a 1 online resource (79 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a COVER; TITLE; COPYRIGHT; Contents; Foreword; Preface; Acknowledgements; Executive summary; 1. Introduction; 2. Overview of the public pharmaceutical sector in Lebanon; 3. Methodology; 4. Results and data presentations; 5. Data analysis and discussion; 6. Recommendations; 7. Conclusions; 8. Resource documents; Annexes.
|
| 588 |
0 |
|
|a Print version record.
|
| 520 |
8 |
|
|a Annotation
|b In recent years, countries of the WHO Eastern Mediterranean Region have made significant achievements in the provision of health services. In the pharmaceutical field, countries have been striving to improve the structures and regulations pertaining to medicines and have progressed in many ways. However, there are still important challenges. The goal of the WHO Good Governance for Medicines programme is to improve the situation of medicines regulation and supply. National transparency assessment is the beginning of a process aimed at bringing about desirable and sustainable changes in the governance of the pharmaceutical sector. These reports present the findings of the first phase of the national Good Governance for Medicines programme in Jordan, Lebanon, Morocco, Pakistan and Syrian Arab Republic.
|
| 650 |
|
0 |
|a Pharmaceutical industry
|x Standards
|z Jordan.
|
| 650 |
|
0 |
|a Pharmaceutical policy
|z Jordan.
|
| 650 |
|
7 |
|a Pharmaceutical industry
|x Standards
|2 fast
|
| 650 |
|
7 |
|a Pharmaceutical policy
|2 fast
|
| 651 |
|
7 |
|a Jordan
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJgMCMwpB3Qrd9t7MBYHG3
|
| 776 |
0 |
8 |
|i Print version:
|a WHO.
|t Measuring Transparency to Improve Good Governance in the Public Pharmaceutical Sector: Lebanon.
|d Geneva : World Health Organization, ©2009
|z 9789290216513
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=538062
|y Click for online access
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=538063
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|